Animal Models For Neurodegenerative Disease

Animal Models for Neurodegenerative Disease: RSC  eBooks & eLearning

Posted by MoneyRich at Jan. 28, 2015
Animal Models for Neurodegenerative Disease: RSC

Animal Models for Neurodegenerative Disease: RSC (RSC Drug Discovery) by Jesus Avila
English | May 24, 2011 | ISBN: 1849731845 | 306 Pages | PDF | 3 MB

In recent years, medical developments have resulted in an increase in human life expectancy. Some developed countries now have a larger population of individuals aged over 64 than those under 14. One consequence of the ageing population is a higher incidence of certain neurodegenerative disorders. In order to prevent these, we need to learn more about them. This book provides up-to-date information on the use of transgenic mouse models in the study of neurodegenerative disorders such as Alzheimer's and Huntington's disease.

Animal Models of Neurological Disease, I: Neurodegenerative Diseases  eBooks & eLearning

Posted by MoneyRich at Jan. 31, 2015
Animal Models of Neurological Disease, I: Neurodegenerative Diseases

Animal Models of Neurological Disease, I: Neurodegenerative Diseases (Neuromethods) (v. 1) by Alan A. Boulton
English | July 29, 1992 | ISBN: 0896032086 | 368 Pages | PDF | 46 MB

to the Animal Models Volumes This and several other volumes in the Neuromethods series will describe a number of animal models of neu- psychiatric disorders. Because of increasing public concern over the ethical treatment of animals in research, we felt it incumbent upon us to include this general preface to these volumes in order to indicate why we think further research using animals is necessary and why animal models of psychi- ric and neurologic disorders, in particular, are so important.

Animal Models for Stem Cell Therapy (repost)  eBooks & eLearning

Posted by roxul at Jan. 8, 2017
Animal Models for Stem Cell Therapy (repost)

Bruno Christ, Jana Oerlecke, "Animal Models for Stem Cell Therapy"
2014 | ISBN-10: 1493914529 | 392 pages | PDF | 11 MB
Animal Models for Human Cancer, Volume 69: Discovery and Development of Novel Therapeutics

Marianne I. Martic-Kehl, Pius August Schubiger, "Animal Models for Human Cancer, Volume 69: Discovery and Development of Novel Therapeutics"
2016 | ISBN-10: 3527339973 | 272 pages | PDF | 4 MB

Improving the Utility and Translation of Animal Models for Nervous System Disorders  eBooks & eLearning

Posted by leonardo78 at March 1, 2016
Improving the Utility and Translation of Animal Models for Nervous System Disorders

Improving the Utility and Translation of Animal Models for Nervous System Disorders by Diana E. Pankevich, Theresa M. Wizemann, Bruce M. Altevogt
Publisher: NASPress | 2013 | ISBN: 0309266335 | 97 pages | PDF | 5,4 MB

This issue discusses potential opportunities for maximizing the translation of new therapies from animal models to clinical practice. The primary focus is to examine mechanisms for increasing the efficiency of …

Animal Models of Neurological Disease, II: Metabolic Encephalopathies and Epilepsies  eBooks & eLearning

Posted by MoneyRich at Jan. 31, 2015
Animal Models of Neurological Disease, II: Metabolic Encephalopathies and Epilepsies

Animal Models of Neurological Disease, II: Metabolic Encephalopathies and Epilepsies (Neuromethods) (v. 2) by Alan A. Boulton
English | July 29, 1992 | ISBN: 0896032116 | 373 Pages | PDF | 29 MB

to the Animal Models Volumes This and several other volumes in the Neuromethods series will describe a number of animal models of neuropsychiatric disorders. Because of increasing public concern over the ethical treatment of animals in research, we felt it incumbent upon us to include this general preface to these volumes in order to indicate why we think further - search using animals is necessary and why animal models of psychiatric disorders, in particular, are so important.

Animal Models for Retinal Diseases, Volume 46 (repost)  eBooks & eLearning

Posted by interes at Sept. 18, 2014
Animal Models for Retinal Diseases, Volume 46 (repost)

Animal Models for Retinal Diseases, Volume 46 (Neuromethods) by Iok-Hou Pang, Abbot F. Clark
English | 2010-02-01 | ISBN: 1607615401 | 234 pages | PDF | 8,9 MB

Retinal diseases are leading causes of irreversible visual impairment and blindness, affecting over 100 million individuals worldwide. Age-related macular degeneration and glaucoma are the leading causes of blindness in the elderly, while diabetic retinopathy is the leading cause of visual impairment in middle-aged individuals. The prevalence of all three of these retinal diseases will continue to increase as our world’s populations continue to age and diabetes becomes endemic.

Animal Models for Stem Cell Therapy  eBooks & eLearning

Posted by arundhati at Sept. 7, 2014
Animal Models for Stem Cell Therapy

Bruno Christ, Jana Oerlecke, "Animal Models for Stem Cell Therapy"
2014 | ISBN-10: 1493914529 | 392 pages | PDF | 11 MB

Animal Models for Retinal Diseases, Volume 46 (Neuromethods) (repost)  eBooks & eLearning

Posted by libr at Jan. 28, 2014
Animal Models for Retinal Diseases, Volume 46 (Neuromethods) (repost)

Animal Models for Retinal Diseases, Volume 46 (Neuromethods) by Iok-Hou Pang, Abbot F. Clark
English | 2010-02-01 | ISBN: 1607615401 | 234 pages | PDF | 8,9 MB

Retinal diseases are leading causes of irreversible visual impairment and blindness, affecting over 100 million individuals worldwide. Age-related macular degeneration and glaucoma are the leading causes of blindness in the elderly, while diabetic retinopathy is the leading cause of visual impairment in middle-aged individuals. The prevalence of all three of these retinal diseases will continue to increase as our world’s populations continue to age and diabetes becomes endemic.
Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop

Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop
by Engineering, and Medicine National Academies of Sciences, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders
English | June 15, 2017 | ASIN: B071GVP5LF | 95 Pages | PDF | 2 MB

Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology.